E-LIB Suche - Ergebnisse für: Van den Reek, Juul M.P.A.

1

Switching to Interleukin-23 Inhibitors After Ineffectivenes..:

Thomas, Sarah E. ; Seyger, Marieke M. B. ; Mangnus, Josje E....
American Journal of Clinical Dermatology. 25 (2024) 4 - p. 685-688 , 2024

Link: https://doi.org/10.1007/..

2

Is Telemedicine Suitable for Patients with Chronic Inflamma..:

Van Enst, Wynanda A. ; Weng, Ying Chao ; Wanten, Sophie A. C....
Acta Dermato-Venereologica. 104 (2024) - p. adv23901 , 2024

Link: https://doi.org/10.2340/..

3

Improved Quality of Life in Patients with Psoriasis Receivi..:

van den Reek, Juul M. P. A. ; van der Leest, Robert J. T. ; Thomas, Sarah E....
Advances in Therapy. 41 (2024) 4 - p. 1594-1605 , 2024

Link: https://doi.org/10.1007/..

4

Impairment in work and activities of daily life in patients..:

van Hal, Tamara W. ; van den Reek, Juul M. P. A. ; Wenink, Mark H....
Journal of Dermatological Treatment. 35 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

5

Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: ..:

Thomas, Sarah E. ; Barenbrug, Liana ; Hannink, Gerjon...
Drugs. 84 (2024) 5 - p. 565-578 , 2024

Link: https://doi.org/10.1007/..

6

Guselkumab induction therapy demonstrates long-lasting effi..:

Rousel, Jannik ; Bergmans, Menthe E. ; van der Meulen, Laura W.J....
Journal of the American Academy of Dermatology. 90 (2024) 2 - p. 395-397 , 2024

Link: https://doi.org/10.1016/..

7

Should we prefer biologics over nonbiological agents in pso..:

Thomas, Sarah E ; van den Reek, Juul M P A
British Journal of Dermatology. 189 (2023) 3 - p. 258-259 , 2023

Link: https://doi.org/10.1093/..

8

Prevalence, risk and severity of SARS-CoV-2 infections in p..:

Kwee, Kevin V. ; Murk, Jean-Luc ; Yin, Qiqi...
Journal of Dermatological Treatment. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

9

Prevalence of chronic urticaria and healthcare usage of pat..:

Soegiharto, Reineke ; Westmeijer, Mike ; Boekema-Bakker, Nicole...
British Journal of Dermatology. 190 (2023) 2 - p. 287-289 , 2023

Link: https://doi.org/10.1093/..

10

Adalimumab combined with methotrexate versus adalimumab mon..:

van Huizen, Astrid M. ; van der Kraaij, Gayle E. ; Busard, Celine I....
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 9 - p. 1815-1824 , 2023

Link: https://doi.org/10.1111/..

11

Development of a New Referral Tool to Identify Psoriasis Pa..:

Van Hal, Tamara W. ; Mulder, Michelle L.M. ; Wenink, Mark H....
Acta Dermato-Venereologica. 103 (2023) - p. adv5269 , 2023

Link: https://doi.org/10.2340/..

12

Efficacy and Safety of Tildrakizumab in Older Patients: Poo..:

Ter Haar, Elke L. M. ; Van den Reek, Juul M. P. A. ; Gaarn Du Jardin, Kristian...
Acta Dermato-Venereologica. 103 (2023) - p. adv17752 , 2023

Link: https://doi.org/10.2340/..

13

How to define a 'super-responder' to biologics in psoriasis..:

Thomas, Sarah E ; van den Reek, Juul M P A ; Seyger, Marieke M B.
British Journal of Dermatology. 189 (2023) 5 - p. 621-622 , 2023

Link: https://doi.org/10.1093/..

14

Direct Comparison of Real-world Effectiveness of Biologics ..:

Van Muijen, Marloes E. ; Thomas, Sarah E. ; Groenewoud, Hans M.M....
Acta Dermato-Venereologica. 102 (2022) - p. adv00712 , 2022

Link: https://doi.org/10.2340/..

15

Global Risk of Bacterial Skin Infections and Herpesviridae ..:

Davidson, Linda ; Van den Reek, Juul M.P.A. ; Van Hunsel, Florence..
Acta Dermato-Venereologica. 102 (2022) - p. adv00648 , 2022

Link: https://doi.org/10.2340/..